Edwards Lifesciences Corp

EWNYSEUSD
87.14 USD
0.52 (0.60%)🟢PRE MARKET (AS OF 06:02 AM EDT)
🟢Market: OPEN
Open?$87.61
High?$87.82
Low?$87.14
Prev. Close?$87.66
Volume?254
Avg. Volume?5.4M
VWAP?$87.76
Rel. Volume?0.00x
Bid / Ask
Bid?$86.10 × 100
Ask?$88.99 × 100
Spread?$2.89
Midpoint?$87.54
Valuation & Ratios
Market Cap?50.5B
Shares Out?575.8M
Float?571.8M
Float %?99.2%
P/E Ratio?46.05
P/B Ratio?4.89
EPS?$1.90
Dividend?0.00%
Ex-Dividend?N/A

Edwards Lifesciences Corp (EW) trades at $87.14 per share. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Jun 2, 2026.

RelatedAMNHSIC
News
Profile
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
Employees
16.0K
Market Cap
50.8B
Industry
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Listed
2000-04-03
Address
ONE EDWARDS WAY
IRVINE, CA 92614
Phone: (949) 250-2500
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+3/3)
Medium-Term (Wave)? Bullish(+2/3)
Short-Term (Ripple)? Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
100
Momentum?
20
Short Sent.?
59
Piotroski F-Score?3/9Weak
Altman Z-Score?12.88Safe
Confidence?58%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.99%Low
Short Interest?11.4M
Days to Cover?2.5
Free Float571.8M
Avg Daily Volume4.5M
Settlement Date2026-05-15
Financial Health
Current Ratio?4.42Strong
Quick Ratio?3.63Strong
Cash Ratio?1.74Strong
Debt/Equity?0.06Low
ValuationRICHLY VALUEDvs 2 peers + S&P 500
Score
39/100
P/E?
Peers
50
S&P
15
46.1PRICEY
P/B?
Peers
33
S&P
38
4.89FAIR
P/S?
Peers
33
S&P
13
8.01HIGH
P/FCF?
Peers
33
S&P
12
46.3PRICEY
EV/EBITDA?
Peers
33
S&P
14
26.1HIGH
EV/Sales?
Peers
33
S&P
18
7.71HIGH
Returns & Efficiency
ROE?
Peers
50
S&P
37
10.6%FAIR
ROA?
Peers
100
S&P
67
8.2%STRONG
Cash Flow & Enterprise
FCF?$1.1B
Enterprise Value?$48.6B
Fundamentals ratios updated end of day